Feb 1, 1997

Atrioventricular node reentry: physiology and radiofrequency ablation

Pacing and Clinical Electrophysiology : PACE
Eric N Prystowsky


Atrioventricular (AV) node reentry has been recognized as a clinical arrhythmia for many years. Earlier basic investigations identified a dual AV conduction system, and atrial echo beats occurred when the refractory period of the slow conduction pathway was shorter than the fast pathway. Subsequent studies in humans confirmed the concept of dual AV node physiology and AV node reentry. Slow-fast AV node reentry (anterograde conduction over the slow pathway and retrograde conduction over the fast pathway) occurs most frequently. The fast-slow and intermediate varieties are much less common. A high (> 95%) cure rate occurs with radiofrequency catheter ablation with experienced electrophysiologists. Most electrophysiologists prefer the posterior approach, which results in absence or very poor conduction over the slow AV node pathway: the PR interval is minimally changed. This approach is highly successful for all three forms of AV node reentry and associated with a 1%-2% incidence of heart block in most experienced laboratories.

Mentioned in this Paper

Biochemical Pathway
Heart Block
Refractory Period
Cardiac Conduction System
Structure of Atrioventricular Node
Electrophysiology (Science)
Entire Atrioventricular Node
Heart Atrium
Catheter Ablation, Transvenous
Cardiac Conduction

About this Paper

Related Feeds

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.